Secukinumab group (Secukinumab Injection):None

2 trials

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

ankylosing spondylitis

Phase 1

To explore the predictive genes of treatment response for ankylosing spondylitis with TNF-a inhibitors and IL-17A inhibitors

Active, not recruitingChiCTR2400088487

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technologyankylosing spondylitis

Start: 2024-08-21Updated: 2024-08-26

Phase 4

Effectiveness of biological agents in ankylosing spondylitis following tapering strategy

Active, not recruitingChiCTR2300071073

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technologyankylosing spondylitis

Start: 2023-05-08Updated: 2023-06-04